2-(1H-Pyrazol-3-yl)pyridine, 98.0%, 25g

Methyl 2-(3-nitrophenyl)acetate, 95.0%, 25g

Inhibitor Cocktail Tissue

8-Bromo-6-chloroimidazo[1,2-a]pyrazine, 95+%, 5g

p-Anisidine-2-sulfonic Acid>97.0%(HPLC)(T)25g

2-Ethyl-4-fluoro-1-nitrobenzene, 97%, 10g

2-methyl-4-phenylnicotinic acid, 95.0%, 250mg

7-amino-5-(2,4-dimethoxyphenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile, 250mg

4-(Benzyloxy)benzene-1,2-diamine, 95.0%, 250mg

4-Methylcyclohexylamine (cis- and trans- mixture)>99.0%(GC)25mL

5-Bromo-1,3-dimethyl-1H-indole-7-carbonitrile, 95%, 25g

(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]propanoate, 98%, 10g

3-Bromo-2-(difluoromethyl)pyridine, 95%, 100mg